or Try an Advanced Search...

    Technical Analysis for WINT - Windtree Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 4.49 -2.48% -0.11
    WINT closed up 13.33 percent on Wednesday, May 15, 2024, on 2.01 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Up
    Historical WINT trend table...
    Date Alert Name Type % Chg
    Slingshot Bearish Bearish Swing Setup -2.48%
    Stochastic Buy Signal Bullish -2.48%
    Wide Bands Range Expansion -2.48%
    Oversold Stochastic Weakness -2.48%
    Slingshot Bearish Bearish Swing Setup 10.52%
    New Uptrend Bullish 10.52%
    Calm After Storm Range Contraction 10.52%
    New 52 Week Low Weakness 10.52%
    Earnings Movers Other 10.52%
    Outside Day Range Expansion 10.52%
    Older End-of-Day Signals for WINT ...

       Recent Intraday Alerts

    Alert Time
    2x Volume Pace about 3 hours ago
    1.5x Volume Pace about 3 hours ago
    Down 2 % about 3 hours ago
    Down 1% about 3 hours ago
    10 DMA Resistance 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    WINT Chart by TradingView
    Basic chart:

    Profile

    Windtree Therapeutics, Inc. engages in the manufacture and development of products for infants and respiratory diseases. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Respiratory Diseases Surfactant Syndromes Neonatology Respiratory Distress Respiratory Distress Syndrome

    Is WINT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 7 Windtree Therapeutics regains compliance with Nasdaq, shares up
    May 7 Windtree Therapeutics Regains Compliance with Nasdaq
    Apr 23 (WINT) - Analyzing Windtree Therapeutics's Short Interest
    Apr 18 Windtree Therapeutics approves reverse stock split
    Apr 18 Windtree Therapeutics Announces Reverse Stock Split
    Apr 17 Windtree Therapeutics GAAP EPS of -$0.95
    Apr 17 Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
    Apr 8 Windtree to buy certain assets of Varian Biopharmaceuticals
    Apr 8 Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing
    Feb 14 Windtree Therapeutics files to sell 608,272 shares for holders
    See more WINT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 35.1
    52 Week Low 3.85
    Average Volume 27,680
    200-Day Moving Average 13.37
    50-Day Moving Average 6.05
    20-Day Moving Average 4.90
    10-Day Moving Average 4.43
    Average True Range 0.66
    RSI (14) 43.18
    ADX 25.94
    +DI 27.74
    -DI 20.08
    Chandelier Exit (Long, 3 ATRs) 5.74
    Chandelier Exit (Short, 3 ATRs) 5.84
    Upper Bollinger Bands 6.15
    Lower Bollinger Band 3.65
    Percent B (%b) 0.38
    BandWidth 50.97
    MACD Line -0.59
    MACD Signal Line -0.57
    MACD Histogram -0.0156
    Fundamentals Value
    Market Cap 34.09 Million
    Num Shares 7.41 Million
    EPS -16.79
    Price-to-Earnings (P/E) Ratio -0.27
    Price-to-Sales 660.53
    Price-to-Book 0.36
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.50
    Resistance 3 (R3) 5.43 5.07 5.35
    Resistance 2 (R2) 5.07 4.84 5.10 5.30
    Resistance 1 (R1) 4.83 4.70 4.95 4.90 5.25
    Pivot Point 4.47 4.47 4.53 4.50 4.47
    Support 1 (S1) 4.23 4.24 4.35 4.30 3.95
    Support 2 (S2) 3.87 4.10 3.90 3.90
    Support 3 (S3) 3.63 3.87 3.85
    Support 4 (S4) 3.70